Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Open-market sale President & CEO sold 30,000 shares at $136.90 ($4,107,000)
  2. 4 Open-market sale Director sold 800,000 shares at an average $100.81 ($80,650,635)
  3. 4 Open-market sale President & CEO sold 30,000 shares at $96.82 ($2,904,600)
  4. 4 Open-market sale EVP and General Counsel sold 9,903 shares at $100.12 ($991,488)
  5. 4 Open-market sale EVP and General Counsel sold 97 shares at $100.00 ($9,700)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes President & CEO gave up 852 shares (to pay taxes)
  8. 4 Open-market sale EVP and Chief Medical Officer sold 262 shares at $88.00 ($23,056)
  9. 4 Open-market sale EVP and General Counsel sold 325 shares at $88.00 ($28,600)
  10. 4 Open-market sale CBO & EVP sold 262 shares at $87.98 ($23,051)
  11. 4 Open-market sale EVP & Chief Commercial Officer sold 220 shares at $88.00 ($19,360)
  12. 4 Open-market sale Pinion John Richard sold 262 shares at $88.00 ($23,056)
  13. 4 Open-market sale EVP & Chief Tech Ops Officer sold 262 shares at $88.00 ($23,056)
  14. 4 Open-market sale SVP, Controller and PAO sold 146 shares at $87.98 ($12,845)
  15. 4 Open-market sale EVP, Finance sold 375 shares at $87.99 ($32,996)
  16. 4 Open-market sale Pinion John Richard sold 2,780 shares at $94.47 ($262,627)
  17. 4 Open-market sale EVP and General Counsel sold 10,000 shares at $95.00 ($950,000)
  18. 4 Grant or award CFO & Executive Vice President acquired 40,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale EVP and General Counsel sold 10,000 shares at $90.00 ($900,000)

Page 12 of 32 · 627 filings